Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Nature Careers
- The Ohio State University
- Technical University of Denmark
- Chalmers University of Technology
- University of California Irvine
- University of Florida
- Aarhus University
- CNRS
- Duke University Medical Center
- Institut Pasteur
- King's College London
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- Saint Louis University
- SciLifeLab
- Stanford University
- Umeå universitet stipendiemodul
- University of Lund
- University of Luxembourg
- University of Maryland, Baltimore
- University of Texas at Dallas
- VIB
- Wroclaw University of Science and Technology
- 12 more »
- « less
-
Field
-
Postdoc position within antibody engineering and therapy in Parkinson’s Disease We are seeking applicants for a 2-year postdoctoral position in Daniel Otzen’s research group at iNANO. This is a fix
-
at Danish Universities under the Danish Ministry of Science, Technology and Innovation . The application must be in English and include a curriculum vitae, degree certificate, a complete list of publications
-
work on antibody isolation, engineering or rational design. 3. Experience mentoring junior researchers or supervising laboratory personnel. Create a Job Match for Similar Jobs Logo About The Ohio State
-
sorting, hybridoma, antibody functional analysis. 2. Prior work on antibody isolation, engineering or rational design. 3. Experience mentoring junior researchers or supervising laboratory personnel
-
The Department of Clinical Microbiology, Umeå University, Sweden, is offering a postdoctoral scholarship within the project of studying mucosal B cell and antibody response. The scholarship is full
-
of Clinical Microbiology is offering a postdoctoral scholarship within the project of studying mucosal B cell and antibody response. The scholarship is full-time (2 years) with access early to mid 2026 or by
-
antibody specificity profiling. KEY RESPONSIBILITIES You’ll join a small team advancing a new screening platform focused on therapeutic antibody specificity. The aim is to deploy this newly developed assay
-
rely almost exclusively on antibodies, which brings reproducibility problems due to lot-to-lot variability and dependence on animal-derived reagents, and drives up setup and running costs. Recent
-
to therapeutic modalities including immune checkpoint blockade, cytokine-based immune modulation, and engineered cellular therapies such as CAR-T platforms. The scholar will contribute to the development and
-
, integrate datasets, and extract actionable biomarkers. Pharmacogenomic & Drug‑Screening Work – Conduct high‑throughput drug libraries (small‑molecule, antibody, targeted agents) on primary leukemia cells and